12th International Cancer, Oncology and Therapy Conference

 

Exploring Breakthroughs in Colorectal Cancer at the 12th International Oncology Conference

Welcome to the blog of the Track 15 session of the 12th International Oncology Conference. This year’s focus on colorectal cancer brings together cutting-edge research, evolving clinical practices, and an urgent call for broader awareness. Whether you're a researcher, clinician, trainee, or advocate, this post aims to highlight major breakthroughs, key challenges, and why you should consider engaging – including submitting your abstract and registering to attend.

Why Colorectal Cancer Matters Now

Colorectal cancer (CRC) remains a major global health issue. According to the National Cancer Institute (NCI), screening and early detection have improved outcomes, yet incidence in younger adults is rising. National Cancer Institute+2Cancer Research Institute+2
Some of the key points:

• Screening can both detect cancer early and remove precancerous polyps, reducing incidence. National Cancer Institute

• Advances in treatment are moving fast — for example, novel immunotherapies and targeted therapies are showing promise. Oncology News Central+1

• However, challenges remain: access to screening, disparities in outcomes, managing metastatic disease, and integrating new technology. Memorial Sloan Kettering Cancer Center+1
  The conference offers an opportunity to gather around these topics, exchange findings, and plan how to translate them into practice.

Key Breakthroughs in Detection & Early Intervention

Detection and early intervention set the foundation for improving survival in colorectal cancer. Some of the breakthroughs we’ll discuss in Track 15 include:

Blood-based / Liquid Biopsy Approaches

Researchers are exploring tests that detect tumour‐derived DNA or other markers in blood (so-called “liquid biopsies”). For example, the NCI notes that circulating tumour DNA (ctDNA) may help identify patients who need additional therapy after surgery. National Cancer Institute
Such approaches could reduce reliance on more invasive methods and help tailor follow-up care more precisely.

New Screening Paradigms & Risk Stratification

In addition to classic methods like colonoscopy and stool-based tests, novel risk stratification (using genetics, microbiome, imaging) is gaining traction. A recent study explored liver-derived radiomic features on CT scans to predict colorectal neoplasia—signalling a new frontier in opportunistic detection. arXiv
This means that routine scans done for other reasons might one day help flag high risk of CRC.

Microbiome, Lifestyle & Prevention

Emerging research links gut microbial profiles, inflammation, diet, and lifestyle more closely to colorectal cancer risk. For instance, a recent e-Cancer article reported that the bacterium Fusobacterium nucleatum, rich in CRC patients’ guts, might suppress immune responses and promote tumour growth. ecancer
Prevention strategies informed by these insights will be an important part of the discussion at the conference.

Breakthroughs in Treatment: From Precision to Immunotherapy

Treatment for colorectal cancer is evolving rapidly. In Track 15, we’ll examine major advances that are reshaping how clinicians and researchers think about this disease.

Immunotherapy for Selected Patients

Some subsets of colorectal cancer (for example those with microsatellite instability-high (MSI-H) or mismatch repair deficiency (dMMR)) respond well to immune checkpoint inhibitors. The NCI summarises that about 15% of stage II/III CRC and 5% of stage IV are MSI-H/dMMR, and immunotherapies like Pembrolizumab or Nivolumab plus Ipilimumab have been approved in such cases. National Cancer Institute+1
This is a big shift from the era when chemotherapy and surgery were nearly the only options.

Novel Targeted Therapies & Combination Strategies

For patients without MSI-H/dMMR, researchers are investigating new combinations: targeted therapy, radiation, and immunotherapy together. One recent article highlights a novel combination therapy (botensilimab/balstilimab) for advanced CRC showing promising responses. Targeted Oncology
Targeted therapy against specific gene mutations (e.g., BRAF mutation, HER2 overexpression) is also gaining ground. National Cancer Institute+1

Treatments for Metastatic Disease & Functional Outcome

Metastatic colorectal cancer (mCRC) used to imply a very poor prognosis. Today, newer modalities are improving both survival and quality of life. For example, a hepatic artery infusion pump has been shown to shrink liver metastases and facilitate surgical removal. Mass General Brigham
The conference will cover how to integrate such advanced approaches into standard care and when to refer to specialised centres.

Translating Discovery into Practice: Challenges, Implementation & Next Steps

Finding breakthroughs is one thing; translating them into clinical practice and broad access is another. At Track 15, we’ll place strong emphasis on implementation and real-world impact.

Addressing Disparities & Access Gaps

Even with breakthroughs, disparities persist: differences in screening uptake, timely diagnosis, and treatment outcomes across socio‐economic, geographic and ethnic lines. The NCI highlights efforts to understand how to boost screening and follow-up in underserved communities. National Cancer Institute
One session will focus on best practices in resource-limited settings, including how to adapt innovations like liquid biopsies effectively.

Infrastructure, Guidelines & Health Systems

Introducing new diagnostic technology or treatment protocols requires robust health-system readiness: laboratories, trained personnel, reimbursement frameworks, and real-time data monitoring. We’ll explore how to bridge the bench-to-bedside gap, including regulatory, payer and logistical dimensions.

Future Trials, Biomarkers and Data Integration

Emerging research is pointing to even more personalised and precise care—for example, using ctDNA to guide adjuvant chemotherapy decisions, or radiomics to stratify patients. National Cancer Institute+1
We’ll discuss how future-proofing research infrastructure, integrating AI and machine learning, and fostering multidisciplinary collaboration are essential next steps.

Why You Should Submit Your Abstract & Attend

Whether you're a researcher, clinician, or trainee, Track 15 offers a unique platform to present your work, network with experts, and stay ahead of the curve. Here’s why you should consider it:

• Opportunity to present cutting-edge data on colorectal cancer in front of an international audience.

• Access to leading thought-leaders, innovators and policy-makers in colorectal cancer screening, treatment and prevention.

• Networking potential: collaborate across disciplines (oncology, surgery, radiology, pathology, health systems).

• Exposure to emerging modalities and cross-border perspectives—especially valuable in regions where CRC trends differ (e.g., younger age at diagnosis, different risk profiles).

• A platform to influence the field—whether your focus is basic science, clinical trials, implementation research or health policy.

Consider submitting your abstract by the deadline (via the link above) and making sure your institution or collaborators know you’re attending.

Registration & Agenda Highlights

Attending the 12th International Oncology Conference gives you full access to Track 15 plus other oncology sessions. Registration opens the door to:

• Full plenary and parallel sessions, including keynote addresses on colorectal cancer.

• Poster sessions and networking receptions where you can engage 1:1 with speakers and delegates.

• Workshops on implementation science, health systems, regulatory pathways and industry innovation.

• Optional satellite symposia and exhibitions featuring latest diagnostics, therapeutics and service delivery models.

Pro tip: Early-bird registration often comes with discounts and priority seating for topical sessions like Colorectal Cancer Breakthroughs. Book early to guarantee a seat in high-interest sessions.

What to Expect & How to Prepare for Track 15

To make the most of the session, here are some practical tips:

• Review emerging literature ahead of the conference: Here are some suggested readings:

• “Advances in Colorectal Cancer Research” from NCI. National Cancer Institute

• “Emerging Frontiers in Colorectal Cancer Therapy” in PMC by Fatemi N. PMC

• Think about your questions: What are the gaps in your practice or research? What barriers exist in your healthcare setting? What are the translational pathways you’re most interested in?

• Prepare to network: Bring business cards, your current abstract or project summary, and be ready for informal discussions with peers and industry partners.

• Identify key sessions you want to attend: Whether you're laser-focused on immunotherapy, prevention or health systems implementation, check the agenda and mark high-priority talks.

• Follow up post-conference: Consider how you can apply what you learn — new protocols, collaborations, funding ideas, or service-delivery improvement projects.

Conclusion: Towards a Better Future for Colorectal Cancer Care

The journey in colorectal cancer research and care is accelerating. From liquid biopsies and radiomics to immunotherapy and targeted treatments, the opportunities are immense. But breakthroughs alone aren’t enough—translation into everyday practice, equitable access and sustained systems change matter just as much.
By submitting your work, attending the 12th International Oncology Conference, and engaging with Track 15, you become part of that journey. Together, we can move from discovery to real-world impact, improving outcomes for patients everywhere.

We look forward to seeing you there, sharing ideas, and pushing the boundaries of what’s possible in colorectal cancer care.

Share Your Findings: https://cancer.utilitarianconferences.com/submit-abstract
Secure Your Spot: https://cancer.utilitarianconferences.com/registration

Exploring Breakthroughs in Colorectal Cancer | Join the 12th International Oncology Conference – April 09–11, 2026 | Dubai, UAE 

#ColorectalCancer #OncologyConference #CancerResearch #CancerAwareness #Oncology #CancerTherapy #GastrointestinalCancer #OncologyExperts #CancerCare #PrecisionOncology #CancerTreatment #OncologySummit #MedicalConference #OncologyCommunity #CancerPrevention #ClinicalOncology #CancerInnovation #DubaiConference #CancerScientists #CancerSurvivorship